Giuseppe Plazzi

1 presentation

• T60. SAFETY AND EFFICACY RESULTS FROM THE PHASE 2 VIBRANCE-1 STUDY OF THE OREXIN 2 RECEPTOR AGONIST ALIXOREXTON IN PATIENTS WITH NARCOLEPSY TYPE 1

  2026 ASCP Annual Meeting